Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 106 citing articles:

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 142
Understanding tumour endothelial cell heterogeneity and function from single-cell omics
Qun Zeng, Mira Mousa, Aisha Shigna Nadukkandy, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 8, pp. 544-564
Closed Access | Times Cited: 84
Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions
Peilin Lu, Dongxue Ruan, Meiqi Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 78
CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications
Yaru Yang, Jiayan Li, Wangrui Lei, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3341-3359
Open Access | Times Cited: 67
The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy
Dechao Feng, Weizhen Zhu, Jie Wang, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 25
Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues
Jiayu Zhang, Tong Lü, Shiqi Lu, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 21, pp. 665-676
Open Access | Times Cited: 38
Comparative analysis of 10X Chromium vs. BD Rhapsody whole transcriptome single-cell sequencing technologies in complex human tissues
Stefan Salcher, Isabel Heidegger, Gerold Untergasser, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28358-e28358
Open Access | Times Cited: 13
Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer
Bangwei Fang, Ying Lu, Xiaomeng Li, et al.
Prostate Cancer and Prostatic Diseases (2024)
Closed Access | Times Cited: 11
Survival strategies: How tumor hypoxia microenvironment orchestrates angiogenesis
Mengchao YANG, Yufeng Mu, Xiaoyun Yu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116783-116783
Open Access | Times Cited: 10
The role of proinflammatory cytokines and CXC chemokines (CXCL1–CXCL16) in the progression of prostate cancer: insights on their therapeutic management
Amin Ullah, Jiao Wang, Bairong Shen
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 9
Prediction of Clinically Significant Prostate Cancer by a Specific Collagen-related Transcriptome, Proteome, and Urinome Signature
Isabel Heidegger, Maria Frantzi, Stefan Salcher, et al.
European Urology Oncology (2024)
Closed Access | Times Cited: 8
Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysis
Siyuan Cheng, Lin Li, Yunshin Yeh, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Applications and emerging challenges of single-cell RNA sequencing technology in tumor drug discovery
Lu Zhang, Yueying Yang, Jianjun Tan
Drug Discovery Today (2025), pp. 104290-104290
Closed Access | Times Cited: 1
Targeting both the enzymatic and non-enzymatic functions of DHODH as a therapeutic vulnerability in c-Myc-driven cancer
Qiang Zhang, Kaisa Cui, Yue Kong, et al.
Cell Reports (2025) Vol. 44, Iss. 3, pp. 115327-115327
Open Access | Times Cited: 1
Experimental in vitro, ex vivo and in vivo models in prostate cancer research
Verena Sailer, Gunhild von Amsberg, Stefan Duensing, et al.
Nature Reviews Urology (2022) Vol. 20, Iss. 3, pp. 158-178
Closed Access | Times Cited: 33
Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophil
Haoxin Peng, Xiangrong Wu, Shaopeng Liu, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 7
Open Access | Times Cited: 15
Unveiling the immunomodulatory dance: endothelial cells’ function and their role in non-small cell lung cancer
Sophia Daum, Lilith Decristoforo, Mira Mousa, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Innate immune cells in vascular lesions: mechanism and significance of diversified immune regulation
Jinjing Wu, Y. Qian, Yang Kuang, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
CXCR4 promotes tumor stemness maintenance and CDK4/6 inhibitors resistance in ER-positive breast cancer
Qiuling Shi, Yang Wang, Yiye Ouyang, et al.
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
Prostate Cancer Bone Metastasis: Molecular Mechanisms of Tumor and Bone Microenvironment
Jiang Hua
Cancer Management and Research (2025) Vol. Volume 17, pp. 219-237
Open Access
The role of liver sinusoidal endothelial cells in metabolic dysfunction-associated steatotic liver diseases and liver cancer: mechanisms and potential therapies
Hanjun Mo, Pengfei Yue, Qiaoqi Li, et al.
Angiogenesis (2025) Vol. 28, Iss. 2
Closed Access
A comprehensive analysis of molecular characteristics of hot and cold tumor of gastric cancer
Chenxi Lv, Tianwei Chen, Jiangtao Li, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Study of immunosenescence in the occurrence and immunotherapy of gastrointestinal malignancies
Daosong Dong, Yu Xue, Haoran Liu, et al.
Seminars in Cancer Biology (2025)
Closed Access
Unleashing the power of peptides in prostate cancer immunotherapy: mechanism, facts and perspectives
Xiaoya Li, Fang Yang, Meijing Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Unraveling the YAP1-TGFβ1 axis: a key driver of androgen receptor loss in prostate cancer-associated fibroblasts
Edward Brunner, Elisabeth Damisch, Melanie Emma Groninger, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Page 1 - Next Page

Scroll to top